Unmet needs in people with high-grade glioma: defining criteria for stepped care intervention.

IF 3.4 Q2 ONCOLOGY JNCI Cancer Spectrum Pub Date : 2024-07-01 DOI:10.1093/jncics/pkae034
Mona M Faris, Haryana M Dhillon, Rachel Campbell, Georgia K B Halkett, Annie Miller, Raymond J Chan, Helen M Haydon, Ursula M Sansom-Daly, Eng-Siew Koh, Tamara Ownsworth, Anna K Nowak, Brian Kelly, Robyn Leonard, Kerryn E Pike, Dianne M Legge, Mark B Pinkham, Meera R Agar, Joanne Shaw
{"title":"Unmet needs in people with high-grade glioma: defining criteria for stepped care intervention.","authors":"Mona M Faris, Haryana M Dhillon, Rachel Campbell, Georgia K B Halkett, Annie Miller, Raymond J Chan, Helen M Haydon, Ursula M Sansom-Daly, Eng-Siew Koh, Tamara Ownsworth, Anna K Nowak, Brian Kelly, Robyn Leonard, Kerryn E Pike, Dianne M Legge, Mark B Pinkham, Meera R Agar, Joanne Shaw","doi":"10.1093/jncics/pkae034","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We aimed to define levels of unmet supportive care needs in people with primary brain tumor and to reach expert consensus on feasibility of addressing patients' needs in clinical practice.</p><p><strong>Methods: </strong>We conducted secondary analysis of a prospective cohort study of people diagnosed with high-grade glioma (n = 116) who completed the Supportive Care Needs Survey-Short Form during adjuvant chemoradiation therapy. Participants were allocated to 1 of 3 categories: no need (\"no need\" for help on all items), low need (\"low need\" for help on at least 1 item, but no \"moderate\" or \"high\" need), or moderate/high need (at least 1 \"moderate\" or \"high\" need indicated). Clinical capacity to respond to the proportion of patients needing to be prioritized was assessed.</p><p><strong>Results: </strong>Overall, 13% (n = 5) were categorized as no need, 23% (n = 27) low need, and 64% (n = 74) moderate/high need. At least 1 moderate/high need was reported in the physical and daily living domain (42%) and the psychological (34%) domain. In recognition of health system capacity, the moderate/high need category was modified to distinguish between moderate need (\"moderate\" need indicated for at least 1 item but \"high\" need was not selected for any item) and high need (at least 1 \"high\" need indicated). Results revealed 24% (n = 28) moderate need and 40% (n = 46) high need. Those categorized as high need indicated needing assistance navigating the health system and information.</p><p><strong>Conclusions: </strong>Using four step allocations resulted in 40% of patients indicating high need. Categories may facilitate appropriate triaging and guide stepped models of healthcare delivery.</p>","PeriodicalId":14681,"journal":{"name":"JNCI Cancer Spectrum","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218915/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Cancer Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncics/pkae034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We aimed to define levels of unmet supportive care needs in people with primary brain tumor and to reach expert consensus on feasibility of addressing patients' needs in clinical practice.

Methods: We conducted secondary analysis of a prospective cohort study of people diagnosed with high-grade glioma (n = 116) who completed the Supportive Care Needs Survey-Short Form during adjuvant chemoradiation therapy. Participants were allocated to 1 of 3 categories: no need ("no need" for help on all items), low need ("low need" for help on at least 1 item, but no "moderate" or "high" need), or moderate/high need (at least 1 "moderate" or "high" need indicated). Clinical capacity to respond to the proportion of patients needing to be prioritized was assessed.

Results: Overall, 13% (n = 5) were categorized as no need, 23% (n = 27) low need, and 64% (n = 74) moderate/high need. At least 1 moderate/high need was reported in the physical and daily living domain (42%) and the psychological (34%) domain. In recognition of health system capacity, the moderate/high need category was modified to distinguish between moderate need ("moderate" need indicated for at least 1 item but "high" need was not selected for any item) and high need (at least 1 "high" need indicated). Results revealed 24% (n = 28) moderate need and 40% (n = 46) high need. Those categorized as high need indicated needing assistance navigating the health system and information.

Conclusions: Using four step allocations resulted in 40% of patients indicating high need. Categories may facilitate appropriate triaging and guide stepped models of healthcare delivery.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高级别胶质瘤患者未满足的需求:确定阶梯护理干预的标准。
背景我们旨在确定原发性脑肿瘤患者未得到满足的支持性护理需求水平,并就临床实践中满足患者需求的可行性达成专家共识:我们对一项前瞻性队列研究进行了二次分析,研究对象是在辅助化疗放疗期间完成支持性护理需求调查-SF34的高级别胶质瘤患者(n = 116)。参与者被分为三类:无需求(在所有项目上均 "无需求")、低需求(在至少一个项目上 "低需求",但无 "中度 "或 "高度 "需求)或中度/高度需求(至少有一项 "中度 "或 "高度 "需求)。对需要优先处理的患者比例的临床应对能力进行了评估:总体而言,13% 的患者(5 人)被归类为无需求,23% 的患者(27 人)为低需求,64% 的患者(74 人)为中度/高度需求。在身体和日常生活领域(42%)和心理领域(34%)至少有一项中度/高度需求。考虑到医疗系统的能力,对中度/高度需求类别进行了修改,以区分:中度需求(至少有一个项目显示 "中度 "需求,但任何项目均未选择 "高度 "需求)和高度需求(至少有一个项目显示 "高度 "需求)。结果显示,24%(n = 28)为中度需求,40%(n = 46)为高度需求。被归类为高需求的人表示需要在医疗系统和信息方面得到帮助:结论:使用四步分配法后,40% 的患者表示有较高需求。分类可促进适当的分流,并指导分步医疗服务模式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JNCI Cancer Spectrum
JNCI Cancer Spectrum Medicine-Oncology
CiteScore
7.70
自引率
0.00%
发文量
80
审稿时长
18 weeks
期刊最新文献
Association between GLP-1RA use and progression of MGUS to Multiple Myeloma among diabetic patients. Sexual Function and Satisfaction in Young Women with Breast Cancer: A Five-Year Prospective Study. County-level racial disparities in prostate cancer specific mortality from 2005 to 2020. Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis. Neighborhood vulnerability and associations with poor health-related quality of life among adult survivors of childhood cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1